The effect of cannabis on urge incontinence in patients with multiple sclerosis: A multicentre, randomised placebo-controlled trial (CAMS-LUTS)

International Urogynecology Journal

Volumn 17, Issue 6, 2006, Pages 636-641

  Freeman, Robert M ^a   Adekanmi, O ^a   Waterfield, M R ^b   Waterfield, A E ^a   Wright, D ^b   Zajicek, J ^b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Cannabinoid; Cannabis; Controlled trial; Multiple sclerosis; Neurogenic detrusor overactivity; Urge incontinence

Indexed keywords

CANNABIDIOL; CANNABINOID; CANNABIS DERIVATIVE; DRONABINOL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETRUSOR DYSSYNERGIA; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICTURITION; MULTICENTER STUDY; MULTIPLE SCLEROSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPASTICITY; URGE INCONTINENCE; URINARY TRACT DISEASE; URINARY TRACT INFECTION; URINE RETENTION; URODYNAMICS;

EID: 33750037938     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-006-0086-x     Document Type: Article

References (29)

1. Betts CD, Dmellow MT, Fowler CJ (1993) Urinary symptoms and the neurological features of bladder dysfunction in multiple-sclerosis. J Neurol Neurosurg Psychiatry 56(3):245-250
2. Goldstein I, Siroky MB, Sax DS, Krane RJ (1982) Neurourologic abnormalities in multiple-sclerosis. J Urol 128(3):541-545
3. Hinson JL, Boone TB (1996) Urodynamics and multiple sclerosis. Urol Clin North Am 23(3):475
4. Sliwa JA, Bell HK, Mason KD, Gore RM, Nanninga J, Cohen B (1996) Upper urinary tract abnormalities in multiple sclerosis patients with urinary symptoms. Arch Phys Med Rehabil 77(3):247-251
5. Nathan PW, Smith NC (1982) The centrifugal pathway for micturition with the spinal cord. J Neurol Neurosurg Psychiatry 21:177
6. Chancellor MB, Blaivas JG (1994) Urological and sexual problems in multiple-sclerosis. Clin Neurosci 2(3-4):189-195
7. Gonor SE, Carroll DJ, Metcalfe JB (1985) Vesical dysfunction in multiple-sclerosis. Urology 25(4):429-431
8. Madersbacher H, Wyndaele JJ, Igawa Y, Chancellor M, Chartier-Kastler E, Kovindha A (2002) Conservative management in neuropathic urinary incontinence. In: Abrams P et al (eds) Incontinence: 2nd international consultation on incontinence, Health Publication Ltd., Plymouth, pp 697-754
9. De Ridder D, Baert L (2000) Vanilloids and the overactive bladder. BJU Int 86(2):172-180
10. de Seze M, Wiart L, Ferriere JM, de Seze MP, Joseph PA, Barat M (1999) Intravesical instillation of capsaicin in urology: A review of the literature. Eur Urol 36(4):267-277
11. Rapp DE, Lucioni A, Katz EE, O'Connor RC, Gerber GS, Bales GT (2004) Use of botulinum-a toxin for the treatment of refractory overactive bladder symptoms: An initial experience. Urology 63:1071-1075
12. Litwiller SE, Frohman EM, Zimmern PE (1999) Multiple sclerosis and the urologist. J Urol 161(3):743-757
13. Burton TA (1979) Urinary retention following cannabis ingestion. JAMA 242(4):351
14. Consroe P, Musty R, Rein J, Tillery W, Pertwee R (1997) The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 38(1):44-48
15. Brady CM, DasGupta R, Wiseman OJ, Dalton CM, Berkley KJ, Fowler CJ (2002) The effect of cannabis based medicinal extract on lower urinary tract dysfunction in advanced multiple sclerosis: Preliminary results. J Neurol Neurosurg Psychiatry 72(1):139
16. Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial. Lancet 362(9395):1517-1526
17. Groutz A, Blaivas JG, Chaikin DC, Resnick NM, Engleman K, Anzalone D, Bryzinski B, Wein AJ (2000) Noninvasive outcome measures of urinary incontinence and lower urinary tract symptoms: A multicenter study of micturition diary and pad tests. J Urol 164(3):698-701
18. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104(12):1374-1379
19. Lose G, Fantl JA, Victor A, Walter S, Wells TL, Wyman J, Mattiasson A (1998) Outcome measures for research in adult women with symptoms of lower urinary tract dysfunction. Neurourol Urodyn 17(3):255-262
20. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: Report from the of the International Standardisation Sub-Committee Continence Society. Neurourol Urodyn 21(2):167-178
21. Artibani W, Andersen JT, Gajewski JB, Ostergard DR, Raz S, Tubaro A (2002) Imaging and other investigations. in: Abrams P et al (eds) Incontinence: 2nd international consultation on incontinence, Health Publication Ltd., Plymouth, pp 697-754
22. Goldstein H (1995) Multilevel statistical models, 2nd edn. Arnold, London
23. Cnaan A, Laird NM, Slasor P (1997) Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med 16(20):2349-2380
24. Coyne KS, Matza LS, Thompson CL (2005) The responsiveness of the Overactive Bladder Questionnaire (OAB-q). Qual Life Res 14:849-855
25. Greenland JE, Brading A (1995) The in-vitro effect of delta-9 tetrahydrocannabinol on the detrusor smooth muscle of the pig. Proceedings of the International Continence Society, Sydney, pp 87-88
26. Ost D, Van der Aa F, De Ridder D (2001) Immunohistochemical study of the cannabinoid receptors CB1 and CB2 in the human bladder. Mult Scler 7(1):S24
27. Pertwee RG, Fernando SR (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118(8):2053-2058
28. Blyweert W, Van der Aa F, De Ridder D (2003) Cannabinoid therapy in detrusor overactivity: Local versus systemic effect in a spinalised rat model. Neurourol Urodyn 22(5):379-380
29. Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB (1996) Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: A prospective study in 24 spinal cord injury patients. J Urol 155(3):1023-1029